ProQR Therapeutics (PRQR) Share-based Compensation (QoQ) (2013 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -129.33% |
| Sep 30, 2022 | 70.93% |
| Jun 30, 2022 | -40.69% |
| Mar 31, 2022 | -34.83% |
| Dec 31, 2021 | 0.68% |
| Sep 30, 2021 | 14.24% |
| Jun 30, 2021 | 17.68% |
| Mar 31, 2021 | -15.26% |
| Dec 31, 2020 | -9.26% |
| Sep 30, 2020 | -1.37% |
| Jun 30, 2020 | 62,546.47% |
| Mar 31, 2020 | -99.94% |
| Dec 31, 2019 | 264.63% |
| Sep 30, 2019 | 10.37% |
| Jun 30, 2019 | -52.47% |
| Mar 31, 2019 | 71,820.55% |
| Dec 31, 2018 | -99.58% |
| Sep 30, 2018 | 11.77% |
| Jun 30, 2018 | 71,280.12% |
| Mar 31, 2018 | -2.70% |
| Dec 31, 2017 | 5.16% |
| Sep 30, 2017 | -99.93% |
| Jun 30, 2017 | 141,625.46% |
| Mar 31, 2017 | -99.96% |
| Dec 31, 2016 | 377,604.70% |
| Dec 31, 2015 | 397,725.78% |
| Mar 31, 2015 | 8.48% |
| Dec 31, 2014 | 26.96% |
| Mar 31, 2014 | 168.48% |
| Dec 31, 2013 | 1,903.05% |